首页> 外文会议>Symposium on Biomathematics >A mathematical model for long-term effect of diethylcarbamazine-albendazole mass drug administration on lymphatic filariasis
【24h】

A mathematical model for long-term effect of diethylcarbamazine-albendazole mass drug administration on lymphatic filariasis

机译:淋巴丝体乙酰丝氨酸二乙基氨基吡吡啶 - 阿贝扎唑类药物施用的长期效果的数学模型

获取原文

摘要

In this paper we discuss a mathematical model for the transmission of lymphatic filariasis disease. The human population is divided into susceptible, latent, acute and chronic subpopulations. Treatment is carried out within the scheme of mass drug administration (MDA) by giving the diethylcarbamazine (DEC) and albendazole (ALB) to all individuals. In the model, we assume that the treatments have direct killing effect to microfilariae, increase of immune-mediated effect. The treated individuals are assumed to remain susceptible to the disease. This is due to the fact that the treatment is only partially effective against macrofilaria. Simulations of the model reveals that DEC-ALB treatment does give significant reduction of acute and chronic compartments at the end of the treatment period and slow down the growth after the treatment before eventually tend to the endemic state. It showed that repeated treatment during MDA is effective to decrease the transmission. This suggests that terminating MDA program after a long period of its application may still effective in controlling the disease.
机译:本文讨论了淋巴丝体疾病传播的数学模型。人口分为易感,潜伏,急性和慢性群体。通过将二乙基氨基吡吡啶(DEC)和Albendazole(ALB)给所有个体,在大规模药物施用(MDA)方案中进行治疗。在该模型中,我们假设该治疗对微生物造成的杀灭作用直接杀死,免疫介导的效果增加。假设治疗的个体仍然易于这种疾病。这是由于治疗仅对宏观拉利拉利拉利有效。该模型的模拟表明,在治疗期结束时,Dec-Alb治疗确实会显着降低急性和慢性隔室,并在治疗后减缓趋于流动状态后的治疗后的生长。它表明,MDA期间的重复治疗有效降低传输。这表明在长期申请后终止MDA计划可能仍然有效地控制疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号